20.07.2013 Views

NATIonAL MARFAn FounDATIon AnnuAL REpoRT 2007

NATIonAL MARFAn FounDATIon AnnuAL REpoRT 2007

NATIonAL MARFAn FounDATIon AnnuAL REpoRT 2007

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

National Marfan Foundation<br />

Annual Report <strong>2007</strong>


22 Manhasset Avenue<br />

Port Washington, NY 11050<br />

800-8-MARFAN<br />

www.marfan.org<br />

At the National Marfan Foundation,<br />

we are dedicated to providing innovative<br />

solutions for people with Marfan syndrome<br />

and related connective tissue disorders.<br />

Our mission is to save lives and improve the quality of life for individuals and<br />

families affected by Marfan syndrome and related connective tissue disorders.<br />

Our goals and objectives are to:<br />

• Expand awareness about Marfan syndrome and related disorders, as well<br />

as the diagnosis and treatment of these conditions.<br />

• Enhance support and access to care for patients with Marfan syndrome<br />

and related disorders throughout the United States.<br />

• Support research that advances knowlege about Marfan syndrome and<br />

related disorders, leading to innovations in diagnosis and treatment.<br />

• Establish trusted partnerships that increase our ability to enhance care<br />

and services for the Marfan syndrome and related disorders community.<br />

Front and back cover photos are of Suzanne Kouri and her son, Yamilito.<br />

Photo credits:<br />

Pages 2, 9, 10, 14, 17, 21 by Tim Joyce.<br />

Front and back covers, pages 6, 13, 24 by Rick Guidotti.<br />

Page 5 by Robert Boyd.<br />

Copyright © 2008 National Marfan Foundation. All rights reserved.


Dear Friends,<br />

It is with great pride that we present the National Marfan Foundation’s <strong>2007</strong><br />

Annual Report, a reflection on recent achievements with a focus on what lies ahead.<br />

Last year, we made significant advances in service to our constituency. Our core<br />

programs, always robust, have expanded in breadth and scope. Local chapters,<br />

network and support groups worked to improve lives and promote healthier local<br />

communities through an increased volunteer force. At our national headquarters,<br />

new educational strategies were created to raise national awareness. We leveraged<br />

donor resources to expand research investments in laboratories worldwide. We<br />

advocated on the legislative front for systemic change. We seized opportunities to<br />

marshal change in your community.<br />

The current Atenolol vs. Losartan in Patients with Marfan Syndrome clinical trial,<br />

testing the potential of losartan as a new drug therapy for Marfan syndrome, is already<br />

changing the way we do business. We are now operating within the environs of new<br />

thinking, and of expanded possibilities, as we keep pace with the needs of today’s<br />

increasingly discriminating Marfan consumer. At this time of heightened awareness<br />

of Marfan syndrome, we have the opportunity to leverage the momentum and<br />

expand interest in this field. In addition, we have the responsibility to recruit people<br />

into the trial and educate and support them throughout the process. It is more<br />

important than ever for people to receive an early and accurate diagnosis to afford<br />

them the opportunity to benefit from new medical interventions.<br />

While the demands will be great, the capabilities of our staff and commitment of our<br />

board ensure that we will meet these challenges with innovative solutions. We will<br />

seize new opportunities for educational product development, increased media outreach<br />

to underserved audiences, expanded support services and strategic investments in<br />

research. We will nurture the momentum we put in motion toward finding a cure.<br />

In the last year, we grew in critical ways, even as we sustained core programs with<br />

great commitment. This report is a perspective on our innovative, convening and<br />

catalytic role in aligning investment resources with strategies that produced tangible<br />

results.<br />

Thank you for your confidence and distinguished partnership.<br />

Joseph R. Gagliano, Jr. Carolyn Levering<br />

Chair President & CEO


The NMF has sponsored research that has fundamentally<br />

changed the approach to diagnosis and treatment of Marfan<br />

syndrome and related disorders.<br />

Alan C. Braverman, M.D.<br />

Professor of Medicine and Director, Marfan Syndrome Clinic<br />

Washington University School of Medicine<br />

Brooke Pulliam


RESEARCH<br />

Fostering research is a priority for the NMF. Each year we fund meritorious projects to the<br />

extent we are able, facilitate research collaborations among scientists worldwide, and coalesce<br />

key government bodies and research institutions for the purpose of advancing knowledge of,<br />

and treatment for, Marfan syndrome. As catalysts in this arena, we continue to strive to improve<br />

diagnostic, medical and surgical solutions so that people with Marfan syndrome and related<br />

disorders have an opportunity to live a full life span.<br />

Clinical Trial Initiative<br />

In <strong>2007</strong>, the critical clinical trial—Atenolol vs. Losartan in Patients with Marfan Syndrome—<br />

began enrolling patients, ages six months to 25 years. This research, which is funded by the<br />

National Heart, Lung and Blood Institute and conducted by the Pediatric Heart Network and<br />

other leading Marfan syndrome clinics, has the potential to alter Marfan syndrome treatment<br />

in the future.<br />

NMF staff worked tirelessly to promote enrollment in this ground-breaking research. Our<br />

proactive outreach included direct mail to 2,000 pediatric cardiologists and 200 geneticists in<br />

the U.S. and exhibits at key medical meetings, including the Scientific Session of the American<br />

Heart Association.<br />

In addition, the Foundation began to provide patient support that made it possible for many to<br />

enroll. This included travel and hotel scholarships as well as free airfare through a partnership<br />

with the National Patient Travel Center.<br />

An additional objective was to maximize the impact of the core clinical trial, which is looking at<br />

the effect of losartan on the aorta, by funding ancillary studies that examine other body systems<br />

affected by Marfan syndrome. After a successful fundraising campaign, the Foundation awarded<br />

$1.7 million in <strong>2007</strong> to fund ancillary studies. The two studies funded were:<br />

• Musculoskeletal phenotype of Marfan patients. Julie Hoover-Fong, MD, Johns Hopkins<br />

University. This research examines the effects of losartan on bone and muscle mass.<br />

• Study of the role of genetic variation in the phenotype variability and response treatment in<br />

patients with Marfan syndrome. Dan Roden, MD, Vanderbilt University Medical Center,<br />

and Bart Loeys, MD, PhD, Ghent University, Belgium. This research examines the potential<br />

connections between responses to different drug therapies (losartan vs. atenolol) and<br />

individual genetic factors.


Aortic Valve Operative Outcomes in Marfan Patients<br />

Many people with Marfan syndrome require surgery to correct aortic root dilatation and aortic<br />

valve dysfunction that leads to aortic tear and rupture. There has not been prior research<br />

comparing aortic valve replacement (AVR) and aortic valve sparing (AVS) surgical interventions<br />

within the framework of one study. In <strong>2007</strong>, we supported this important work through more<br />

than $250,000 in funding. In addition, we increased our public outreach efforts, resulting in<br />

increased patient enrollment. We also leveraged this study to attract new corporate funders.<br />

Traditional Research Grant Program<br />

Since 1989, our objective has been to ensure that the most promising Marfan research is<br />

supported. The NMF Research Grant Program has provided initial financial support for<br />

various Marfan syndrome-related projects. Our 19th Annual Research Fund Drive generated<br />

$235,000. This enabled us to award $150,000 in traditional research grants. The three studies<br />

awarded $50,000 each were:<br />

• Mechanism of latent TGF-β activation in Marfan cells. Daniel B. Rifkin, PhD, New York<br />

University School of Medicine. This study is focusing on how and why the protein called<br />

transforming growth factor-beta ( TGF-β) is increased in Marfan cells.<br />

• Pathophysiology of skeletal deformities in Marfan syndrome. Luca Carta, PhD, Mount Sinai<br />

School of Medicine, NJ. This is an investigation into how a mutation in the gene that<br />

causes Marfan syndrome (fibrillin-1) creates skeletal features and deformities.<br />

• Characterization of the mechanisms of fibrillin gene regulation. Peter Robinson, PhD,<br />

Institute of Medical Genetics, Charite Universitatsmedizin, Berlin, Germany. This is an<br />

examination of the possible explanation of variable expression in Marfan syndrome.<br />

In addition, the NMF awarded the second half of a 2006 two-year $100,000 grant to<br />

Michael Reiss, MD, The Cancer Institute of New Jersey, for his study, Structure-function<br />

studies of transforming growth factor-β receptor mutations in Marfan-like syndromes. This study<br />

has combined the connective tissue field with cancer and developmental biology by using an<br />

insect model to understand how these mutations cause Loeys-Dietz syndrome.<br />

Victor A. McKusick Fellowship Program<br />

To support future leaders in the research arena, the NMF awards the Victor A. McKusick<br />

Fellowship each year. This nurtures young talent in research and supports promising scientists<br />

who are investigating important areas of Marfan syndrome.<br />

In <strong>2007</strong>, a one-year McKusick Fellowship grant ($75,000) was awarded to Raymond Eid, MD,<br />

Department of Surgery, Yale University. Dr. Eid’s study, Role of IL-17A in Marfan syndrome,<br />

may expand our understanding of TGF-β/IL-17A interaction and the role of inflammation<br />

in aortic breakdown and enlargement.


Daniel B. Rifkin, PhD


Micah Amdur-Clark


ADVOCACY &<br />

GOVERNMENT<br />

RELATIONS<br />

In <strong>2007</strong>, the NMF continued to advocate for government policies and resources that improve<br />

access to healthcare for the Marfan syndrome and related connective tissue disorders community<br />

and support research funding for these disorders. We pursued our legislative agenda with<br />

vigor and expanded our affiliations and partnerships with supportive organizations and coalitions<br />

to help us reach our goals.<br />

Our advocacy program this year resulted in a number of significant accomplishments,<br />

including:<br />

• Congressional recommendations in the Fiscal Year 2008 Health and Human Services<br />

Appropriations Bill encouraging the Centers for Disease Control and Prevention,<br />

National Heart, Lung and Blood Institute, and National Institute of Arthritis and<br />

Musculoskeletal and Skin Diseases to expand their research and awareness programs on<br />

Marfan syndrome.<br />

• Establishment of an NHLBI Working Group on Research in Marfan Syndrome and<br />

Related Disorders, chaired by Dr. Hal Dietz.<br />

• Outreach to the leadership of CDC’s National Center on Birth Defects and Developmental<br />

Disabilities regarding the need for early diagnosis and prevention of aortic dissection.<br />

• The NMF, as one of only a handful of organizations selected, testified at a Social Security<br />

Administration Outreach Hearing in Washington on “Compassionate Disability Allowances”<br />

for patients with rare diseases.<br />

• NMF Advocacy Action Alerts distributed to the Foundation’s grass-roots network<br />

facilitated communication with legislators regarding increased funding for the National<br />

Institutes of Health, the Genetic Information Non-Discrimination Act and legislation<br />

about the expansion of Medigap supplemental insurance coverage.


SUPPORT &<br />

MEMBER SERVICES<br />

The NMF takes very seriously its support services role on the national level, and is intent<br />

on providing one-on-one, customized support to all who need it—whether they are seeking<br />

diagnosis, newly diagnosed or facing new challenges in their Marfan journey. At the same<br />

time, the Foundation is equally committed to expanding its grass-roots network so that<br />

volunteers from coast to coast can find the peer support they need locally and do their part<br />

to advance the NMF’s mission in their own backyards.<br />

Information Resource Center<br />

Our Information Resource Center (IRC), accessible through our toll-free number, 800-8-<br />

MARFAN, and our website, www.marfan.org, provides accurate, current, disorder-related<br />

information to the public, health care professionals, patients and their families. Our registered<br />

nurse and licensed social worker speak with callers and answer email correspondence Monday<br />

through Friday, 9 a.m. to 5 p.m. Eastern Time. In <strong>2007</strong>, IRC staff responded to approximately<br />

4,500 phone and email inquiries and distributed more than 3,000 information packets on<br />

Marfan syndrome and related disorders.<br />

This year, the IRC played an expanded role in serving Marfan clinics nationwide. The NMF<br />

provided the clinics with new plain-language publications for recently-diagnosed patients and<br />

their families. Our professional staff also assisted nurses and genetic counselors who encountered<br />

difficult patient care case questions by creating an e-list forum to share and acquire information.<br />

Growing the National Volunteer Network<br />

The National Volunteer Network (NVN), consisting of Chapters, Network Groups, Support<br />

Groups and individual volunteers, carries out the NMF mission at the local level. In <strong>2007</strong>,<br />

volunteers worked diligently to raise public and medical awareness, provide peer support and<br />

raise funds for NMF programs and research.<br />

This year, approximately 60 groups around the country conducted grass-roots initiatives that<br />

are aligned with the NMF mission. They organized fundraisers, including tie-ins with Starbucks<br />

and Whole Foods; they partnered with the touring company of the Broadway show, Rent, to<br />

generate awareness as the show was performed in various cities; and they organized local<br />

meetings for group members to learn about Marfan syndrome from local experts and develop<br />

bonds with each other.


Mary Burchett and her mother, Cindy<br />

The National Volunteer Network has allowed me to find fellowship<br />

with people who suffer from the same pain and frustration that I have<br />

experienced. As a Network Group leader, I have valued the opportunity<br />

to repay what the NMF has given me.<br />

Mary Burchett<br />

Group Leader, Central Kentucky Network Group


The NMF taught me how to be an aggressive advocate<br />

for change and improvement of medical care for our<br />

multi-system disorder.<br />

Anthony Smith<br />

Brooklyn, NY<br />

Anthony Smith and his daughter, Jennifer


Introducing the Teen Web Page<br />

To address the unique issues and concerns of teens with Marfan syndrome, the NMF created a<br />

new teen web page. Utilizing the technology that is most comfortable for teens, the Foundation<br />

began using the Internet to speak directly to the teen-aged Marfan community—providing<br />

answers to teens’ common medical questions, telling them about Marfan events that would<br />

be of interest to them, and offering fashion tips to help them dress comfortably despite their<br />

typically long, disproportionate body. The website also provides for interaction through which<br />

young people with Marfan syndrome can find a way to get involved with the NMF as they<br />

share hopes, fears and dreams.<br />

Presenting the Annual Conference<br />

Each year, the NMF partners with a leading medical institution to host a conference for people<br />

affected by Marfan syndrome and related disorders. The conference is educational, as well as<br />

supportive, life-affirming and life-saving.<br />

The Stanford University campus in Northern California was brimming with excitement,<br />

discovery and learning in July <strong>2007</strong> when 500 affected individuals and family members,<br />

physicians and world Marfan experts convened for the NMF’s 23rd Annual Conference.<br />

Patient evaluations, medical presentations, small group workshops, special activities, programs<br />

for children and teens, and events for young adults transformed those who came eager to<br />

allay fears, renew their hope and find new ways to cope.<br />

Ninety-five NMF members, half of whom were children, were awarded NMF Conference<br />

Scholarships from the Foundation totaling close to $30,000.


EDUCATION<br />

& AWARENESS<br />

The NMF effectively leveraged opportunities to promote awareness of Marfan syndrome and<br />

related disorders among the general public and the medical community. By securing media<br />

coverage, we reached millions via television, radio, newspapers and magazines. This year’s media<br />

accomplishments moved us closer to our goal to make “Marfan syndrome” a household word.<br />

In addition to our consumer media campaign, we target specific healthcare professionals to<br />

increase early diagnosis and to ensure that affected people get appropriate treatment—either<br />

on a regular basis or in an emergency situation. Two key audiences targeted in <strong>2007</strong> were<br />

school nurses, who are on the frontline of care for our nation’s children, and emergency<br />

nurses, who play a critical role in the care of patients with a potentially fatal aortic dissection.<br />

<strong>2007</strong> Media Highlights<br />

The NMF’s track record in high profile media continued this year. Woman’s Day magazine,<br />

which has a circulation of 4.2 million, included a feature article by NMF member Kari Dostalik,<br />

of Iowa, whose young daughter, Haley, has Marfan syndrome. This heartfelt, first person<br />

account was both informative and emotional, as Kari chronicled how Haley was diagnosed<br />

and the decision to enroll her in the clinical trial.<br />

The Foundation was equally successful on national television, with a segment about Marfan<br />

syndrome on NBC’s Today Show, which reaches millions of Americans every day. The segment,<br />

filmed primarily at the NMF Annual Conference, aired in November. It featured the Marfan<br />

journey of one of our youngest members, seven-year-old Brooke Pulliam of Missouri, as it<br />

provided viewers with key information about Marfan syndrome and showcased the support<br />

that the NMF provides the Marfan community. The piece also communicated the hope that<br />

now exists due to the exciting research underway.<br />

Media coverage also got a boost in the summer, as we leveraged our Annual Conference at<br />

Stanford University. The San Francisco media responded, based on the excitement stirred by<br />

Stanford University participating in the critical research as a clinical trial site. Both the ABC<br />

and Fox network affiliate stations produced a Marfan syndrome segment and the San Francisco<br />

Examiner published an article about the disorder.<br />

Throughout the year, articles appeared in daily newspapers and broadcast stories aired in<br />

markets large and small, covering the various activities of individuals in our National<br />

Volunteer Network. This coverage increased awareness about Marfan syndrome and related<br />

disorders and drove people to the NMF website for information about getting evaluated for<br />

diagnosis and connecting to the NMF.


Michelle Cripps


Sophia and Christian D’Angelo


Reaching the School Nurse<br />

This year, the NMF completed Marfan Syndrome: Need-to-Know Information for the School<br />

Nurse CD-ROM, a project funded by a grant from the American Legion Child Welfare<br />

Foundation. The CD-ROM was targeted to members of the National Association of School<br />

Nurses through direct mail, through an exhibit at their national conference and at regional<br />

association meetings, as well as through articles in nursing publications. As a result, more<br />

than 2,000 CD-ROMs were disseminated to school nurses from coast to coast.<br />

In an online survey of nurses who requested the CD-ROM, it was revealed that 43 percent of<br />

respondents either have, or have had, a student with Marfan syndrome. In addition, close to<br />

one-third of respondents admitted to not having any knowledge of Marfan syndrome at all.<br />

Their comments showed their appreciation of the materials:<br />

In the past year I have found at least five undiagnosed elementary kids. I wish every<br />

association/foundation would create a similar CD for specific pediatric disorders.<br />

I appreciate your organization being there to empower parents and children with<br />

Marfan syndrome.<br />

Thank you for recognizing that school nurses are valuable for diagnosis, support and<br />

education.<br />

I would like to know a lot more so I can educate teachers about this. Then, we will better<br />

understand the condition and how it affects our students who have Marfan syndrome.<br />

Promoting the Emergency Medicine Campaign<br />

Dissemination of our Emergency Medicine Campaign kit, consisting of comprehensive<br />

materials about Marfan syndrome and aortic dissection, continued. Approximately 2,000<br />

Emergency Medicine Campaign kits have been distributed.<br />

A new resource, Aortic Dissection: Red Flags for the Emergency Triage Nurse, was created this<br />

year. This pocket guide was funded by the Jonathan Larson Fund of the NMF. Our direct<br />

market campaign reached 5,700 emergency nurse managers and directors of emergency<br />

departments of 4,050 hospitals. We also secured coverage in trade media, which reached<br />

thousands of emergency nurses nationwide.


ORGANIZATIONAL<br />

CAPACITY BUILDING<br />

In <strong>2007</strong>, we celebrated the successful conclusion of the clinical trial fundraising initiative.<br />

This secured the funding necessary for the NMF to provide grants to ancillary studies for the<br />

clinical trial, as well as patient support, assistance and education, to ensure that the dream of<br />

this breakthrough science is maximized.<br />

In addition, we were able to strengthen our membership, build relationships with a broad circle<br />

of partners and increase and diversify our fundraising capabilities. This enabled us to expand<br />

our organizational capacity so that we can build on today’s achievements and accomplish<br />

even more in the future.<br />

Growing Partnerships<br />

The NMF enjoys long-time relationships with the National Organization for Rare Disorders<br />

and The Genetic Alliance. The Foundation continues to meet the stringent Standards of<br />

Excellence set by the National Health Council (NHC). Our continued membership in the<br />

NHC and Health First–America’s Charities has given us the opportunity to network with<br />

other leading voluntary health organizations.<br />

Further bolstering our standing in the nonprofit world, the NMF earned its fourth consecutive<br />

4-star rating from Charity Navigator, America’s largest independent evaluator of charities.<br />

This is the highest rating awarded; it indicates that the NMF, as compared to other charities<br />

in the U.S., is successfully managing its finances in an efficient and effective manner.<br />

Special Event: HeARTworks Annual Gala<br />

In <strong>2007</strong>, HeARTWorks, held at Cipriani 42nd Street in New York City, raised a record $1.1<br />

million for the National Marfan Foundation. Chaired by Ted Knetzger and Jay Levine, RBS<br />

Greenwich Capital; O. Wayne Isom, MD, Weill Cornell Medical Center; Sir Anthony Dowell;<br />

John Kander; and Albert Stephenson, the Marfan Gala was a unique showcase of artistconceptualized<br />

hearts, a silent and live auction and performances by legendary stars of stage<br />

and film, Patti Lupone and Mandy Patinkin, and Broadway Kids.<br />

Honorable tribute was paid to three extraordinary honorees who received the Foundation’s<br />

Hero with a Heart Awards: Award-winning actor and choreographer Ann Reinking; Ben<br />

Carpenter, Vice Chair, Greenwich Capital Markets; and Antonio Gotto, MD, Suzanne Weiss<br />

Dean of Weill Medical College of Cornell University. The corporate host for the gala was<br />

Karen Murray, Liz Claiborne, Inc., and New York City Mayor Michael Bloomberg was<br />

honorary chair. NBC-TV’s Ann Curry served as master of ceremonies.


Ann Reinking and Mayor Michael Bloomberg<br />

Supporting the HeARTworks Gala is our family's way of connecting to<br />

the Marfan community. We know that our contributions go directly to<br />

the Foundation's life-saving programs and services and make a real<br />

difference for all those affected.<br />

Britt & Dave Traugott<br />

Alpharetta, GA


STATEMENT OF FINANCIAL ACTIVITIES<br />

Years ended June 30, <strong>2007</strong> and June 30, 2006<br />

Changes In Net Assets:<br />

Revenues and gains:<br />

Unrestricted<br />

Temporarily<br />

Restricted<br />

Year Ended<br />

June 30, <strong>2007</strong><br />

Year Ended<br />

June 30, 2006<br />

Contributions $ 6,663,461 – $ 6,663,461 $2,119,378<br />

Memorials 114,530 – 114,530 78,128<br />

Membership dues 81,474 – 81,474 134,321<br />

National Marfan Conference 171,080 – 171,080 201,102<br />

Program revenue 19,063 – 19,063 28,235<br />

Net investment income 439,027 – 439,027 189,519<br />

Events, net of expenses of<br />

$599,722 and $299,419<br />

773,146 – 773,146 800,654<br />

Revenues temporarily restricted (6,351,762) $6,351,762 – –<br />

Total revenues and gains 1,910,019 6,351,762 8,261,781 3,551,337<br />

Expenses:<br />

Program services:<br />

Research and grants 1,279,400 – 1,279,400 1,034,611<br />

Public information 359,796 – 359,796 625,029<br />

Patient services 770,197 – 770,197 639,371<br />

Subtotal 2,409,393 – 2,409,393 2,299,011<br />

Supporting services:<br />

Management and general 241,833 – 241,833 228,681<br />

Fund raising 349,320 – 349,320 364,502<br />

Subtotal 591,153 – 591,153 593,183<br />

Expenses temporarily restricted (1,470,055) 1,470,055 – –<br />

Total expenses 1,530,491 1,470,055 3,000,546 2,892,194<br />

Increase (decrease) in net assets 379,528 4,881,707 5,261,235 659,143<br />

Net assets at beginning 4,417,151 1,961,946 6,379,097 5,719,954<br />

Net assets at end $ 4,796,679 $ 6,843,653 $ 11,640,332 $ 6,379,097<br />

For a copy of the NMF’s complete audited financial statements for the years ended June 30, <strong>2007</strong> and 2006, go to www.marfan.org or<br />

write to the National Marfan Foundation, 22 Manhasset Avenue, Port Washington, NY 11050.


REVENUES FY07<br />

2%<br />

1%<br />

1%<br />

8%<br />

5%<br />

11%<br />

26%<br />

10%<br />

EXPENSES FY07<br />

81%<br />

12%<br />

43%<br />

Contributions<br />

Memorials<br />

Membership Dues<br />

Conference<br />

Net Investment Income<br />

Net Event Income<br />

Research & Grants<br />

Public Information<br />

Patient Services<br />

Fund Raising<br />

Management & General


STATEMENT OF FINANCIAL POSITION<br />

June 30, <strong>2007</strong> and June 30, 2006<br />

ASSETS<br />

June 30, <strong>2007</strong> June 30, 2006<br />

Current Assets:<br />

Cash $383,163 $301,192<br />

Short-term investments 2,365,137 2,336,512<br />

Unconditional promises to give 1,149,895 337,819<br />

Other current assets 66,443 53,060<br />

Total current assets 3,964,638 3,028,583<br />

Property and Equipment:<br />

Net of accumulated depreciation $309,926 and<br />

$265,390<br />

878,577 858,432<br />

Other Assets:<br />

Long-term investments 3,669,165 2,738,671<br />

Long-term unconditional promises to give 3,403,674 –<br />

Total other assets 7,072,839 2,738,671<br />

Total assets $11,916,054 $6,625,686<br />

LIABILITIES AND NET ASSETS<br />

Current Liabilities:<br />

Accrued liabilities $116,377 $166,537<br />

Deferred conference income 159,345 80,052<br />

Total current liabilities 275,722 246,589<br />

Net Assets:<br />

Unrestricted:<br />

General funds 2,943,948 2,806,266<br />

Board designated funds 1,852,731 1,610,885<br />

Temporarily restricted 6,843,653 1,961,946<br />

Total net assets 11,640,332 6,379,097<br />

Total liabilities and net assets $11,916,054 $6,625,686<br />

For a copy of the NMF’s complete audited financial statements for the years ended June 30, <strong>2007</strong> and 2006, go to www.marfan.org or<br />

write to the National Marfan Foundation, 22 Manhasset Avenue, Port Washington, NY 11050.


Paul Hartmann


MAJOR DONORS<br />

The NMF extends sincerest gratitude to all those who contributed financially during our<br />

<strong>2007</strong> fiscal year. We list here those who have contributed amounts of $1,000 and above.<br />

Platinum<br />

($1,000,000 and above)<br />

Anonymous<br />

Silver Circle<br />

($250,000–$999,999)<br />

Nick & Whiteley Wheeler<br />

Mr. & Mrs. Joel E. Smilow<br />

Vital Projects Fund<br />

Bronze Circle<br />

($100,000–249,999)<br />

Chris & Pam Heaney<br />

RBS Greenwich Capital<br />

Ms. Ann Reinking<br />

Benefactor<br />

($50,000–$99,999)<br />

Mr. & Mrs. Benjamin Carpenter<br />

Randy and Susan Falco<br />

St. Jude Medical Foundation<br />

Patron<br />

($25,000–$49,999)<br />

Joseph R. Gagliano, Jr. & Walter Smith<br />

JC Penney Company<br />

Gary & Mary Kauffman<br />

St. Jude Medical Foundation<br />

Stanford University & Clinics<br />

Allen & Company Inc.<br />

American Heart Association, Inc.<br />

American Legion Child Welfare<br />

Foundation<br />

Frank J. Antun Foundation<br />

AOL LLC<br />

Mr. & Mrs. Allan Larson<br />

Liz Claiborne Foundation<br />

New York Presbyterian Hospital<br />

Northern California Chapter of the NMF<br />

Optima Fund Management<br />

The Starr Foundation<br />

George J. Volan, M.D.<br />

Henry & Joan T. Wheeler<br />

Sponsor<br />

($10,000–$24,999)<br />

Aaron & Betty Lee Stern Foundation<br />

Boston Scientific Corp.<br />

BWF Foundation, Inc.<br />

DMK International<br />

Mr. & Mrs. William Floyd III<br />

Barbara & Mark Heller<br />

Mr. & Mrs. Mel Ilberman<br />

Kellwood Company<br />

KPMG, LLP<br />

The Lehman Brothers Foundation<br />

Jonathan & Barbara Lerman<br />

Macy’s/Bloomindale’s<br />

March of Dimes Foundation<br />

Marissa Walk Fundraiser<br />

Medtronic Foundation<br />

Ms. Karen B. Murray<br />

Neuco, Inc.<br />

Mrs. Barbara Neustadt<br />

Northern Illinois Chapter of the NMF<br />

Ms. Daphne Rubin Vega<br />

Mrs. Elna Schonholtz<br />

Sholton Foundation<br />

The Shubert Organization<br />

Syms<br />

Thornberg Charitable Foundation<br />

Mr. Keith G. Turner<br />

John & Mary Sholton Witte<br />

Supporter<br />

($5,000–$9,999)<br />

American Express Foundation<br />

Century 21 Associates Foundation<br />

Charmer Sunbelt Group<br />

Steve G. Crombe & Will Rubino<br />

Dr. Scholl Foundation<br />

Mr. Walter Friedrichs<br />

Edwin & Katherine Knetzger<br />

Mr. & Mrs. Steven Lefkowitz<br />

Jerry & Judith Lerman<br />

Jay & Tammy Levine<br />

The Levy Group<br />

Ms. Deirdre Mahaney<br />

Mr. Jonathan Mason<br />

Harold & Ellen McElhinny<br />

Kathleen Mimnagh, MD<br />

Melissa & Alfred Morris<br />

Ms. Vivienne Murray<br />

Ms. Juliana O’Neill<br />

Pioneer Credit Fundraiser<br />

Ross Stores, Inc.<br />

Mr. Morris Sachs<br />

Diane Sixsmith, MD<br />

Mr. Lawrence N. Skeats<br />

Suzie Hayes-Schwartz & Andy Schwartz<br />

TJX Companies<br />

Mr. Allan Williams<br />

Partner<br />

($1,000–$4,999)<br />

ABM Janitorial Services<br />

Mr. Richard Adamski<br />

Mr. & Mrs. Ken Adelberg<br />

Aetna Giving Campaign<br />

Ken and Ilana Akoundi<br />

Cyndi Allen Fundraiser<br />

Alpha Phi Omega Theta Upsilon<br />

Fundraiser<br />

Altair Eyewear<br />

Mr. & Mrs. Luis Arias<br />

Mr. & Mrs. Scott D. Avitabile<br />

Ben & Margaret Ann Aycock<br />

Baden Local Network<br />

Baker Street Trust<br />

Mr. Nigel Banyard<br />

Mr. R. Douglas Barnhart<br />

Mr. Raymond H. Bateman<br />

Mr. & Mrs. Michael W. Baumgartner<br />

Ms. Jane Bender<br />

Ms. Joan Bernhard<br />

Dr. & Mrs. Charles Berst<br />

Christina & Mark Bilsky & Ann Powers<br />

Ms. Irene Bishop<br />

Mr. Carmont Blitz<br />

Mr. Paul Boudreau<br />

Mr. & Mrs. Bob Bower<br />

Alan & Rebecca Braverman<br />

Roger & Danielle Burrus<br />

California Tip Toppers<br />

Ms. Karen Castellano &<br />

Mr. Jerry Newirth<br />

Paul and Dorothy Cayo<br />

Central Arizona Tall Society<br />

Ceplenski-Murphy & Good Neighbors<br />

Fundraiser<br />

CFO Fund<br />

Charles Komar & Sons<br />

Mr. & Mrs. Paul R. Charron<br />

Chazen Foundation<br />

Chef & Brewer’s Dinner Fundraiser<br />

Raymond & Joanne Chevallier<br />

Chocolate Lovers Fantasy Night<br />

Fundraiser<br />

Mr. George T. Christ


Mrs. Priscilla C. Ciccariello<br />

Jeffery & Marty Cokin<br />

Mr. Rick Cotton<br />

Julie & Dennis Culley<br />

Ms. Elizabeth Darling<br />

Mr. George Davala<br />

Joanne & Michael Day<br />

Teri and Ken A. Dean<br />

Mr. & Mrs. James Dresser<br />

Drink for a Cure Fundraiser<br />

Bruce & Ellen England<br />

Bruce English & Laurie Hammel<br />

Mr. Mark Epstein<br />

Mr. Milton Farbstein<br />

Mr. Daniel Faucetta<br />

Mr. Mark E. Ferguson<br />

Mr. & Mrs. Robert Ferris<br />

Fishman & Tobin<br />

Brian & Beverly Freeman<br />

Gabriel Brothers Inc<br />

Mr. James Garbus<br />

Mr. Juan Robles Garcia<br />

Mr. Robert J. Garry<br />

Rabbi Marc Gellman<br />

GGLO, LLC.<br />

Ms. Judy Gibaldi<br />

Mr. Sheldon Goldfarb<br />

Stanley Goldstein, MD<br />

Michael Goldstein &<br />

Therese Vandenberg<br />

GQ Magazine<br />

Grace Jones Richardson Trust<br />

Mr. Scott Graham<br />

Mr. & Mrs. Alan Grainger<br />

Greater St. Louis Area Marfan<br />

Chapter of the NMF<br />

Greves Family Charity Dance<br />

Mr. John M. Grimshaw<br />

Guinea Entertainment<br />

Ms. Rehana Haniff<br />

Hartmarx Charitable Foundation<br />

Ms. Joann Hayssen<br />

Heart of Iowa Chapter of the NMF<br />

Hedy Ltd.<br />

Mr. & Mrs. Daniel Heimowitz<br />

Ms. Dorothy Helphand<br />

Henry's Hearts Foundation, Inc.<br />

Mr. Mark Herman<br />

Mrs. Anne H. Hinds<br />

Roy & Sandra Hoffman<br />

Dr. & Mrs. Charles Hollis, Jr.<br />

Hyperion<br />

ICM<br />

Mr. & Mrs. Barry Ilberman<br />

Jackon, PTP Inc.<br />

Mr. Doug Jakubowski<br />

Mr. & Mrs. Allan Janoff<br />

Mr. & Mrs. Lincoln Kaiser<br />

Mr. J. F. Kay<br />

Knothe<br />

Mr. Barry Knox<br />

Mr. Kenneth Kolker<br />

Suzanne & Yamil Kouri<br />

Mr. & Mrs. David S. Kriss<br />

Ms. Jacqueline Laipply<br />

Adam & Amy Leibner<br />

Ms. Carolyn Levering<br />

Ms. Kathy M. Livingston<br />

Liz Claiborne Shoes<br />

Loehmann’s<br />

Ms. Tricia Kordalski<br />

Lord & Taylor<br />

Mr. Robert E. Lotwin<br />

Louisville, KY Local Network RENT<br />

Fundraiser<br />

Mr. Robert Lutz<br />

Mr. Michael Lyublinsky<br />

Kathy Magee Fundraiser<br />

Ms. Debra Malbin<br />

Marsal Family Foundation<br />

Harry & Anna Masi<br />

David & Sheila McLean<br />

Mr. & Mrs. Gerald McNiece<br />

Mr. & Mrs. Rudy Meckel, III<br />

Mr. Ernest J. Meinhardt, MD<br />

Merck Partnership for Giving<br />

Mr. & Mrs. Bruce Michelich<br />

Ms. Carol Miller<br />

Flora Mincer, MD<br />

Mobile 8 Apparel Corp.<br />

Ms. Brenda Montera<br />

Mrs. Dorothy Moore<br />

Mr. & Mrs. Robert Moran<br />

Ms. Cherna Moskowitz<br />

Motoring for Marfan Fundraiser<br />

Mr. & Mrs. Joseph Moyer<br />

Mr. Ryan Mullaney<br />

Mr. C. J. Murray<br />

Nat Nast Company<br />

National Instruments<br />

Jeanette Navia Blogathon<br />

Mr. & Mrs. Bill Neustadt<br />

Jon & Julie Neustadt<br />

New York Hospital Medical Center of<br />

Queens<br />

Mr. William O’Connor<br />

Jim & Karen O’Keefe<br />

Bernard & Rosemarie Oliveri<br />

On the One<br />

Ms. Pamela Orenstein<br />

Mr. Wayne Oster<br />

P R Painting Co.<br />

Mrs. Kathleen Pace<br />

Paramount Tall Club of Chicago<br />

Nicholas & Carol Paumgarten<br />

Jerry & Eleanor Pettus<br />

Dr. & Mrs. Frank Pollaro<br />

Ms. Alecia Porter<br />

Reed E. Pyeritz, M.D., Ph.D.<br />

Elaine & Robert Raisler<br />

Randa Associates<br />

Blair & Susan Ranneberger<br />

Ms. Merle Reskin<br />

Edward Roberts & Elaine Krauss<br />

Mr. & Mrs. Randy Rogers<br />

Mr. & Mrs. Michael W. Rohrer<br />

Dr. & Mrs. Thomas Romo<br />

Ron Chereskin Studios, Inc.<br />

Mr. & Mrs. Andrew Roos<br />

Mr. Peter Roos<br />

Mr. & Mrs. Marc Rosenthal<br />

Ross Store, Inc.<br />

Rotary Club of Monroeville<br />

Meg & Stewart Russell<br />

Ms. Diana M. Ryan-Assatly<br />

Paul & Alison Savage<br />

Mr. Richard Savitt<br />

Mr. Michael Schlanger<br />

Mr. & Mrs. Robert Schwarzenbek<br />

Ms. Sondra Scott<br />

Terry Scheiner & Jose Seligson, MD<br />

Lesley & Andrew Serenyi<br />

Ms. Jennifer Shaffer<br />

Ms. Nancy Shea<br />

Dr. & Mrs. Howard Siegel<br />

Mr. Stephen Skowronek<br />

Mr. & Mrs. Howard Socol<br />

Mr. & Mrs. Michael Sosko<br />

Specialized Construction Sites &<br />

Services<br />

Ms. Elise Sinay Spilker<br />

Sheila & Bob Stone<br />

Mr. & Mrs. Roland Strick<br />

Sucherman Consulting Group, Inc.<br />

Mr. & Mrs. Mitchell Sussman<br />

Swimwear-Anywhere, Inc.<br />

Mr. Peter Talbert<br />

Mr. Richard Tang<br />

Mr. Lee Terrill<br />

Mr. Alex Thurlow<br />

Mr. Jon Tirtinsky<br />

Roberta & Peter Tomback<br />

Mr. & Mrs. Michael S. Tracey<br />

Robyn & Douglas Troob<br />

Mr. Jon Tullis<br />

Mr. & Mrs. Mike Van Eekeren<br />

Ms. Katharine Vestal<br />

Ms. Ann Watt<br />

Mr. Josh Weeks<br />

Mr. David Wells<br />

Tom White & Nancy Tove<br />

Paul & Gail Whiting<br />

Cheryl & Dave Williams<br />

Mrs. Caryn Wojtowicz<br />

Mr. Paul Yablon<br />

Ms. Lisa Zicari


There is going to be a critical need for the Marfan community<br />

and for investors to recognize that we’ve made great strides, but<br />

that there are going to be new challenges and new opportunities<br />

to overcome those challenges. This is a long-term partnership.<br />

Hal C. Dietz, M.D.<br />

Victor A. McKusick Professor of Genetics and Medicine<br />

Director, William S. Smilow Center for Marfan Syndrome Research<br />

Johns Hopkins University<br />

Patrick Bowman (bottom) and Reid Bowman


Board of Directors<br />

Officers<br />

Joseph R. Gagliano, Jr., Chair, New York<br />

Whiteley Wheeler, Vice Chair, California<br />

Karen Murray, Secretary, New York<br />

Jim Sidorchuk, Treasurer, New York<br />

Susan Falco, Executive Committee<br />

Member-at-Large, New York<br />

Members-at-Large<br />

Steve Crombe, Florida<br />

Teri Dean, Iowa<br />

Thomas Fitzgerald, New Jersey<br />

Heather Holmes Floyd, Massachusetts<br />

Barbara Heller, Maryland<br />

Gary Kauffman, Florida<br />

Todd Krueger, California<br />

Gavin Lindberg, Maryland<br />

Steve Marpman, New York<br />

Kathleen Mimnagh, MD, West Virginia<br />

Diane M. Sixsmith, MD, New York<br />

Jon Tullis, Pennsylvania<br />

Mary Sholton Witte, Alaska<br />

Priscilla Ciccariello, Chair Emeritus, New York<br />

Scientific Advisory Board<br />

Bjorn Olsen, MD, PhD, Chair<br />

Harvard Medical School<br />

Victor A. McKusick, MD<br />

Johns Hopkins Hospital<br />

Craig T. Basson, MD, PhD<br />

New York Presbyterian Hospital–Weill Cornell<br />

Medical Center<br />

John C. Carey, MD<br />

University of Utah Health Sciences Center<br />

P. Michael Conneally, PhD<br />

Indiana University School of Medicine<br />

Darwin Prockup,<br />

Tulane University Health Sciences Center<br />

E. Helene Sage, PhD<br />

Benaroya Research Institute<br />

Christine Seidman, MD<br />

Harvard Medical School<br />

Robert W. Thompson, MD<br />

Washington University School of Medicine<br />

Professional Advisory Board<br />

Dianna Milewicz, MD, PhD, Chair<br />

University of Texas Houston Health Science Center<br />

Barbara Bowles Biesecker, MS<br />

National Human Genome Research Institute, NIH<br />

Alan C. Braverman, MD<br />

Washington University School of Medicine<br />

Peter H. Byers, MD<br />

University of Washington School of Medicine<br />

Duke Cameron, MD<br />

Johns Hopkins Hospital<br />

Heidi Connolly, MD<br />

Mayo Clinic<br />

Joseph S. Coselli, MD<br />

Baylor College of Medicine and<br />

St. Luke’s Episcopal Hospital<br />

Jessica G. Davis, MD<br />

New York Presbyterian Hospital–Weill Cornell<br />

Medical Center<br />

Richard B. Devereux, MD<br />

New York Presbyterian Hospital–Weill Cornell<br />

Medical Center<br />

Hal Dietz, MD<br />

Johns Hopkins Hospital<br />

Clair Francomano, MD<br />

Harvey Institute for Human Genetics<br />

Sylvia A. Frazier-Bowers, DDS, PhD<br />

University of North Carolina at Chapel Hill<br />

Irene Maumenee, MD<br />

Johns Hopkins Hospital<br />

D. Craig Miller, MD<br />

Stanford University School of Medicine<br />

Reed E. Pyeritz, MD, PhD<br />

University of Pennsylvania School of Medicine<br />

Francesco Ramirez, PhD<br />

UMDNJ—Robert Wood Johnson School<br />

of Medicine<br />

Lynn Y. Sakai, PhD<br />

Oregon Health Sciences University<br />

Paul D. Sponseller, MD<br />

Johns Hopkins Hospital<br />

Vincent L. Gott, MD, Member Emeritus<br />

Johns Hopkins Hospital<br />

Victor A. McKusick, MD, Member Emeritus<br />

Johns Hopkins Hospital<br />

Carolyn Levering<br />

President & CEO

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!